After Hours
$
38.25
Change
-0.11 -0.29%
Volume
Volume 7,897
Jan 22, 2021, 7:56 p.m.
Quotes are delayed by 20 min
Previous close
$ 37.78
$ 38.36
Change
+0.58 +1.54%
Day low
Day high
$37.48
$38.52

52 week low
52 week high
$31.43
$48.25

Market cap
$94.22B
Average volume
4.65M
P/E ratio
11.91
Rev. per Employee
$433,051
EPS
3.22
Dividend
0.50
Div yield
5.21%
Ex dividend date
11/12/20
MarketWatch News on GSK
-
FDA approves first long-acting HIV drug combination
- Associated Press
-
It's Time to Buy Post-Brexit British Stocks
- Rupert Steiner
-
Best Income Investments for 2021
- Andrew Bary
-
European stocks climb on COVID-19 vaccine optimism and stimulus-deal hopes
- Barbara Kollmeyer
-
Government Asks Moderna for More Covid-19 Shots
- Bill Alpert
-
Stocks Close With Losses for the Week
- Alexandra Scaggs,
-
Sanofi and Glaxo Delay Their Covid Vaccine
- Bill Alpert
- Loading more headlines...
Analyst Ratings
-
Johnson & Johnson: Analyst Recommendations and Target Price
- MarketRealist.com
-
Analysts See a 9.5% Upside for SNY Stock over the Next Year
- MarketRealist.com
-
Analysts’ Recommendations for Valeant in June
- MarketRealist.com
Other News on GSK
-
- Seeking Alpha
-
Why is U.S. vaccine rollout taking longer than expected?
- Seeking Alpha
-
FDA OK's Janssen's HIV drug combo Cabenuva
- Seeking Alpha
-
AbbVie, Roche, Glaxo Are Experts at Product Launches
- GuruFocus.com
-
Merck KGaA, GSK end Phase 3 trial for cancer drug; shares fall
- Seeking Alpha
-
H.C. Wainwright raises Vir Biotechnology price target by 25%
- Seeking Alpha
-
Companies Race to Develop Drugs That Stay Ahead of Mutations
- Joseph Walker
-
Top Stocks Emerging From The 2021 Best Places To Work
- Seeking Alpha
-
Veeva: Not Enough Risk In This Winning SaaS Platform
- Seeking Alpha
-
The world will have to live with COVID forever - Moderna CEO
- Seeking Alpha
- Loading more headlines...
Press Releases on GSK
-
Global Pulmonary Drug Delivery Devices Market to Surpass US$ 59.09 Bn by 2027
- Market Insight Reports
-
Epilepsy Drugs Market to See Major Growth by 2025 | Cephalon, Pfizer, AbbVie, Bausch Health
- Market Insight Reports
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com